NK and T Cell Immunological Signatures in Hospitalized Patients with COVID-19
COVID-19로 입원한 환자의 NK 및 T 세포 면역학적 특징
Article
[키워드] Activation
acute respiratory syndrome
analysed
caused
CD16
CD25
CD56
CD69
China
Clinical severity
Concentration
control groups
coronavirus
coronavirus 2
correlation
COVID-19
COVID-19 infection
COVID-19 patient
cytokine
cytokine release
Cytokines
cytomegalovirus
died
Direct
enrolled
flow cytometry
Frequency
healthy subject
hospitalised patient
human population
IL-6
immune response
immunology
increase in
inhibitory
involved
lung transplant
maintain
Mild
moderate
modulate
Multiplex assay
NK cell
NK cells
NKG2A
overexpression
Patient
patients with COVID-19
PD-1
phenotype
progression
reported
respiratory
SARS-COV-2 infection
serum
serum cytokines
Severe acute respiratory syndrome
severe COVID-19 patients
severe disease
signature
significantly higher
Stimulation
stratified
subset
Survivors
T cell
T cell subset
T cells
T-cell responses
targeted therapy
Viral
viral infections
with COVID-19
Wuhan
[DOI] 10.3390/cells10113182 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/cells10113182 PMC 바로가기 [Article Type] Article